Epidemiology of Tinea: A Current Perspective |
Conferences
eMediNexus Coverage from: 
Epidemiology of Tinea: A Current Perspective
Dr Madhu Rengarajan, Chennai,  23 January 2019
Coronavirus Live Count Map India

remove_red_eye 792 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Dermatology

0 Read Comments                

T. mentagrophytes common co-dominant pathogen.Effect of topical steroid of tinea management: causes local immunosuppression which leads to longer duration of treatment in order to elicit a response.No need to use more than 200 mg of itraconazole.Griseofulvin 750 mg longer duration, with endpoint of clinical cure....
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now